| 000 | 01190 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515033519.0 | ||
| 264 | 0 | _c20060801 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a1871-5206 | ||
| 024 | 7 |
_a10.2174/187152006777698132 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTao, Zhi-Fu | |
| 245 | 0 | 0 |
_aChk1 inhibitors for novel cancer treatment. _h[electronic resource] |
| 260 |
_bAnti-cancer agents in medicinal chemistry _cJul 2006 |
||
| 300 |
_a377-88 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCheckpoint Kinase 1 |
| 650 | 0 | 4 |
_aChemotherapy, Adjuvant _xmethods |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 |
_aDNA Damage _xdrug effects |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemical synthesis |
| 650 | 0 | 4 |
_aProtein Kinases _xdrug effects |
| 700 | 1 | _aLin, Nan-Horng | |
| 773 | 0 |
_tAnti-cancer agents in medicinal chemistry _gvol. 6 _gno. 4 _gp. 377-88 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/187152006777698132 _zAvailable from publisher's website |
| 999 |
_c16433030 _d16433030 |
||